Browsing Tag
IL-2 mutant fusion protein
1 post
Simcere’s SIM0278 enters Phase II trial in China: Could IL-2 Treg fusion therapy transform atopic dermatitis care?
Simcere’s SIM0278 enters Phase II in China for atopic dermatitis. Explore how its IL-2 Treg selectivity could redefine treatment for autoimmune skin diseases.